MedMen Plunges After Scrapping PharmaCann Merger; Marijuana Stocks Slide California-based marijuana retailer MedMen (OTC:MMNFF) on Tuesday said it would terminate its merger with PharmaCann and appointed a new CFO, killing off a deal that would have made it one of the biggest cannabis companies in the U.S. MedMen stock plummeted, while Canadian marijuana stocks reclaimed gains. The announcement came a little less than a month after MedMen said the deal cleared a regulatory hurdle that moved the transaction closer to completion. The merger had been expected to close at the end of the year. MedMen was not immediately available for comment. The company reports fourth-quarter results on Oct. 28. MedMen also named Zeeshan Hyder as its new CFO, effective immediately, representing the latest turnover at the top, amid concerns about the company's spending habits. The cannabis retailer said it terminated Michael Kramer, who had served at that post, on Monday. #medmen #stocks #plunges #pharmacannis #slide #marijuanastocks #money #currency #cash #regulations #holysmokestv #holysmokes #holysmokescrafts #oneman #solo #cannabis #reform #legalization #safeaccess #news #ismokecannabis #medicalcannabis #thc #cbd #breal #massroots #rawlife #rawlife247 #losangeles #california (at Los Angeles, California) https://www.instagram.com/p/B3aV-WnBChC/?igshid=1wak6ucivatty